Keywords: Ipsen, Debipharm, Decapeptyl, prostate cancer, Recordati, silodosin, Prostatic hyperplasia

Ipsen debuts Decapeptyl in France, Recordati gains EU clearance for silodosin

Article | 04 February 2010

French specialty drugmaker Ipsen and Swiss biopharmaceutical group Debiopharm have announced the launch by Ipsen in France of Decapeptyl (triptorelin ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Ipsen

Watson Pharmaceuticals

Go to company listing